The aim of my proposal is to examine the in vivo functions and the mechanisms of action of novel inhibitory costimulatory molecules PD-PDL and B7-H3 in allograft rejection with the goal of harnessing their function to achieve allograft tolerance. This topic has great clinical relevance for transplantation in general as blockade of conventional positive T cell costimulatory pathway such as B7-CD28 has not been effective in reproducibly inducing tolerance in stringent murine transplant models as well as in larger animals such as primates. An important theme of my proposal is that harnessing physiologic mechanisms of regulation by novel negative T cell costimulatory pathways in addition to positive T cell costimulatory blockade are critical to achieve tolerance in humans. I have generated extensive data about the role of negative costimulatory pathways CTLA4-B7 and PD-1/PDL in CD4 and CDS mediated alloimmune responses in vivo. I also have promising preliminary data about the role of the recently described member of CD28 family, B7-H3 in a vascularized cardiac model. I plan to extend these studies using a number of unique tools that will enable me to dissect the functions, mechanisms and interactions of negative and positive costimulatory pathways in regulating alloimmune responses in vivo. These include well established animal models, novel gene knockout animals targeting specific costimulatory molecules, agents to target novel costimulatory pathways and finally elegant models of CD8+ and CD4+ TCR transgenic mice that allow tracking of alloreactive T cell responses in vivo. The Mentored Clinical Scientist Development Award will provide me with the critical opportunity to further expand my knowledge in immunology necessary for achieving independence. My mentor's and co-mentor's laboratories provide an ideal environment to accomplish the aims of my project because of their strong background in transplantation immonology, their collaborative momentum and their exemplary didactic and ethical curricula. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08AI064335-01A2
Application #
7263396
Study Section
Allergy & Clinical Immunology-1 (AITC)
Program Officer
Prograis, Lawrence J
Project Start
2007-06-01
Project End
2010-05-31
Budget Start
2007-06-01
Budget End
2008-05-31
Support Year
1
Fiscal Year
2007
Total Cost
$119,115
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
D'Addio, Francesca; Boenisch, Olaf; Magee, Ciara N et al. (2013) Prolonged, low-dose anti-thymocyte globulin, combined with CTLA4-Ig, promotes engraftment in a stringent transplant model. PLoS One 8:e53797
Riella, L V; Watanabe, T; Sage, P T et al. (2011) Essential role of PDL1 expression on nonhematopoietic donor cells in acquired tolerance to vascularized cardiac allografts. Am J Transplant 11:832-40
De Serres, Sacha A; Vadivel, Nidyanandh; Mfarrej, Bechara G et al. (2011) Monocyte-secreted inflammatory cytokines are associated with transplant glomerulopathy in renal allograft recipients. Transplantation 91:552-9
Ueno, Takuya; Yamada, Akira; Ito, Toshiro et al. (2011) Role of nuclear factor of activated T cell (NFAT) transcription factors in skin and vascularized cardiac allograft rejection. Transplantation 92:e26-7
Riella, Leonardo V; Ueno, Takuya; Batal, Ibrahim et al. (2011) Blockade of Notch ligand ?1 promotes allograft survival by inhibiting alloreactive Th1 cells and cytotoxic T cell generation. J Immunol 187:4629-38
De Serres, Sacha A; Yeung, Melissa Y; Mfarrej, Bechara G et al. (2011) Effect of biologic agents on regulatory T cells. Transplant Rev (Orlando) 25:110-6
Boenisch, Olaf; D'Addio, Francesca; Watanabe, Toshihiko et al. (2010) TIM-3: a novel regulatory molecule of alloimmune activation. J Immunol 185:5806-19
Yamaura, K; Boenisch, O; Watanabe, T et al. (2010) Differential requirement of CD27 costimulatory signaling for naïve versus alloantigen-primed effector/memory CD8+ T cells. Am J Transplant 10:1210-20
Yamaura, K; Watanabe, T; Boenisch, O et al. (2010) In vivo function of immune inhibitory molecule B7-H4 in alloimmune responses. Am J Transplant 10:2355-62
De Serres, Sacha A; Sayegh, Mohamed H; Najafian, Nader (2009) Immunosuppressive drugs and Tregs: a critical evaluation! Clin J Am Soc Nephrol 4:1661-9

Showing the most recent 10 out of 12 publications